Ignite Creation Date:
2025-12-24 @ 4:23 PM
Ignite Modification Date:
2026-04-20 @ 1:00 AM
Study NCT ID:
NCT01085266
Status:
TERMINATED
Last Update Posted:
2016-10-12
First Post:
2010-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease
Sponsor:
Medivation, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DIM20EXT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |